Description
This product utilizes γδ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R22-4). We employs the HBV (SP6-BFP-β-catenin-SmaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Adaptive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R22-4
Species Reactivity
Human
Cell Source
γδ T cells
Sensor Gene
BFP
Promoter
SP6
Effector Gene
β-catenin
Insertion Sites
SmaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.91
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.